Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH-Reference-Cited by-同舟云学术

Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH

Published:2019-06 Issue: Volume:144 Page:377-389
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Boeckmans Joost,Buyl Karolien,Natale Alessandra,Vandenbempt Valerie,Branson Steven,De Boe Veerle,Rogiers Vera,De Kock Joery,Rodrigues Robim M.,Vanhaecke Tamara

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

2. The global NAFLD epidemic;Loomba;Nat. Rev. Gastroenterol. Hepatol.,2013

3. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;Metabolism,2016

4. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat. Med.,2018

5. Steatohepatitis: A tale of two“hits”?;Day;Gastroenterology,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches;Antioxidants;2024-07-26

2. Concomitant NAFLD Facilitates Liver Metastases and PD-1-Refractory by Recruiting MDSCs via CXCL5/CXCR2 in Colorectal Cancer;Cellular and Molecular Gastroenterology and Hepatology;2024

3. A multicellular liver organoid model for investigating hepatitis C virus infection and non-alcoholic fatty liver disease progression;Hepatology;2023-11-17

4. Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis;European Journal of Pharmacology;2023-10

5. Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review;World Journal of Hepatology;2023-08-27